Synaptic Function in the Nematode C. Elegans
Document text
Principal Investigator: ERIK M JORGENSEN Organization: UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH Fiscal Year: 2024 Award: $323,587 Funding agency: National Institute of Neurological Disorders and Stroke Communication between nerve cells takes place by the release of neurotransmitters at synapses. Signaling can be extremely rapid – transmitting information via hundreds of action potentials per second. It is not possible to synthesize new synaptic vesicles at this pace, so rapid recycling is essential. Although endocytosis at the synapse is at the core of synaptic transmission, the debate about the mechanism has continued for over 40 years without resolution. We recently discovered that synaptic vesicle endocytosis at synapses in the nematode C. elegans and mouse hippocampal neurons occurs as rapidly as 30-50 ms rather than 30 seconds, as determined previously. Our preliminary results suggest that this process requires synaptotagmin and interacting adaptors. Aim 1. Synaptotagmin. We will determine if ultrafast endocytosis and vesicle budding is defective in the absence of synaptotagmin in C. elegans. Aim 2. Adaptors. Synaptotagmin interacts with two mu-homology domain proteins: stonin and AP2- µ2. We will determine if ultrafast endocytosis is defective in stonin mutants and vesicle regeneration is defective in AP2 mutants. We will also determine whether these proteins are localized to endocytic domains at the synapse. Aim 3. Cargo. We will determine if synaptic vesicle components synaptotagmin and synaptobrevin are enriched at endocytic sites before stimulation and whether they are recovered by ultrafast endocytosis in rat hippocampal neuron cultures. There is growing evidence that understanding synaptic vesicle endocytosis will have direct impact on applied health research, since mutations in endocytosis play causative roles in Parkinson's Disease and contribute to Alzheimer's Disease. It is our hope that understanding the process of endocytosis may lead to drug therapies for these diseases in the future. Finally, we are developing innovative new techniques that will aid other researchers by bringing new weapons to bear on these and other problems. Terms: <AD dementia><AP2><AP2 Protein><AP2TF Protein><Action Potentials><Activator Protein 2><Acute><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimers Dementia><Ammon Horn><Applications Grants><Area><Assay><Binding><Bioassay><Biological Assay><C 2a><C elegans><C. elegans><C.elegans><C2a><C2b><Caenorhabditis elegans><Calcium><Cell Communication><Cell Communication and Signaling><Cell Interaction><Cell Signaling><Cell membrane><Cell-to-Cell Interaction><Clathrin><Common Rat Strains><Communication><Cornu Ammonis><Cytoplasmic Membrane><Defect><Degenerative Neurologic Disorders><Disease><Disorder><Drug Therapy><Electron Microscopy><Endocytosis><Endosomes><Exhibits><Exocytosis><Failure><Freezing><Future><Genetic Alteration><Genetic Change><Genetic defect><Grant Proposals><Health><Hippocampus><Immunofluorescence><Immunofluorescence Immunologic><Intracellular Communication and Signaling><Investigators><Lead><Measures><Mediating><Membrane><Mice><Mice Mammals><Modeling><Molecular><Molecular Interaction><Motor Cell><Motor Neurons><Murine><Mus><Mutation><Natural regeneration><Nematoda><Nematodes><Nerve Cells><Nerve Unit><Nervous System Degenerative Diseases><Nervous System Diseases><Nervous System Disorder><Neural Cell><Neural Degenerative Diseases><Neural Transmission><Neural degenerative Disorders><Neurocyte><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><Neurologic Disorders><Neurological Disorders><Neurons><Paralysis Agitans><Parkinson><Parkinson Disease><Pb element><Peptide Domain><Pharmacotherapy><Plasma Membrane><Play><Primary Parkinsonism><Primary Senile Degenerative Dementia><Process><Protein Domains><Proteins><Rat><Rats Mammals><Rattus><Receptosomes><Recycling><Regeneration><Research><Research Personnel><Researchers><Resolution><Retrieval><Role><Signal Transduction><Signal Transduction Systems><Signaling><Site><Sorting><Speed><Surface><Synapses><Synaptic><Synaptic Transmission><Synaptic Vesicle P38 Membrane Protein><Synaptic Vesicle Protein P38><Synaptic Vesicles><Synaptophysin><TFAP2 Protein><Techniques><Tertiary Protein Structure><Testing><Time><Transmission><Vesicle><activator protein AP-2><biological signal transduction><complement 2a><complement 2b><complement C2a><complement C2a fragment><complement C2b><complement C2b fragment><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><drug treatment><enhancer-binding protein AP-2><genome mutation><heavy metal Pb><heavy metal lead><hippocampal><innovate><innovation><innovative><membrane structure><motoneuron><mutant><neurodegenerative illness><neurological disease><neuronal><neurotransmitter release><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><optogenetics><plasmalemma><pressure><primary degenerative dementia><recruit><regenerate><resolutions><roundworm><senile dementia of the Alzheimer type><sensor><social role><superresolution imaging><superresolution microscopy><synapse><synapse function><synaptic function><synaptobrevin><synaptotagmin><trafficking><transcription factor AP-2><transcription factor AP2><transmission process><vesicle-associated membrane protein><weapons>